Kinetic Characterization of Tissue-Type Plasminogen Activator (t-PA) and t-PA Deletion Mutants

Summary

The binding of t-PA to fibrin is mediated both by its “finger” (F) and its “kringle 2” (K2) domain. In addition, these domains are involved in the stimulation of t-PA activity by fibrin. We analyzed the kinetic characteristics of Glu-plasminogen activation by t-PA and a set of t-PA deletion mutants in the absence and the presence of desA-fibrin. In the absence of desA-fibrin, the activity of t-PA (variants) is determined by the presence of the pro tease domain, irrespective of the composition of the amino-terminal heavy chain. In the presence of the cofactor desA-fibrin, the activity of t-PA (variants) is dependent on the domain composition of the heavy chain. The activity of t-PA is stimulated 2,400 fold by desA-fibrin, whereas the activity of the mutant lacking the K1 domain (del. Kl) increases 936 fold in the presence of this cofactor. Mutants lacking either the K2 domain (del. K2) or the F domain (del. F) exhibit an enhanced activity upon desA-fibrin addition of 200 and 210 fold, respectively. DesA-fibrin has no stimulatory effect on the activity of the mutant containing only the serine-protease domain (del.FE Kl K2) nor on the activity of the variant containing only the Kl domain and the serine-protease domain (del. FE K2). Furthermore, we determined the relative fibrin affinity of each t-PA variant, which is similarly dictated by the composition of the heavy chain.

• REFERENCES

• 1 Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 77-89
• 2 Tate KM, Higgins DL, Holmes WE, Winkler ME, Heyneker HL, Vehar GA. Functional role of proteolytic cleavage at arginine-275 of human t-PA as assessed by site-directed mutagenesis. Biochemistry 1987; 26: 338-343
• 3 Violand BN, Sodetz JM, Castellino FJ. The effect of epsilon-amino caproic acid on the gross conformation of plasminogen and plasmin. Arch Biochem Biophys 1975; 170: 300-305
• 4 Suenson E, Lutzen O, Thorsen S. Initial plasmin degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem 1984; 140: 513-522
• 5 Rijken DC, Groeneveld E. Isolation and functional characterization of the heavy and light chains of human t-PA. J Biol Chem 1986; 261: 3098-3102
• 6 Dodd I, Fears R, Robinson JH. Isolation and preliminary characterisation of active B-chain of recombinant t-PA. Thromb Haemostas 1986; 55: 94-97
• 7 MacDonald ME, van Zonneveld A-J, Pannekoek H. Functional analysis of the human t-PA protein: the light chain. Gene 1986; 42: 59-67
• 8 van Zonneveld A-J, Veerman J, Pannekoek H. Autonomous functions of structural domains on human t-PA. Proc Natl Acad Sci USA 1986; 83: 4670-4674
• 9 Verheijen JH, Caspers MPM, Chang GTG, De Munk GAW, Pouwels PH, Enger-Valke BE. Involvement of finger domain and kringle-2 domain of t-PA in fibrin binding and stimulation of activity by fibrin. EMBO J 1986; 5: 3525-3530
• 10 Ny T, Elgh F, Lund B. The structure of the human t-PA gene: correlation between intron and exon structure to functional and structural domains. Proc Natl Acad Sci USA 1984; 81: 5355-5359
• 11 Deutsch DG, Mertze ET. Plasminogen: purification from plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 12 van Zonneveld A-J, Veerman H, Brakenhoff JPJ, Aarden LA, Cajot JF, Pannekoek H. Mapping of epitopes on human t-PA with recombinant deletion mutant proteins. Thromb Haemostas 1987; 57: 82-86
• 13 Kramer W, Drutsa V, Jansen HW, Kramer B, Pflugfelder M, Fritz H-J. The gapped duplex DNA approach to oligonucleotide-directed mutation construction. Nucleic Acids Res 1984; 12: 9441-9456
• 14 de Vries C, Veerman H, Pannekoek H. Identification of the domains in t-PA involved in augmented binding to fibrin after limited digestion with plasmin. J Biol Chem 1989; 264: 12604-12610
• 15 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
• 16 Morrisey JH. Silver staining of proteins in polyacrylamide gels: a modified procedure with enhanced sensitivity. Anal Biochem 1981; 117: 307-310
• 17 Norrman B, Wallen P, Ranby M. Fibrinolysis mediated by t-PA: disclosure of a kinetic transition. Eur J Biochem 1985; 149: 193-200
• 18 Beckmann R, Geiger M, Binder RB. Plasminogen activation by t-PA in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. J Biol Chem 1988; 263: 7176-7180
• 19 Tran-Thang C, Kruithof EKO, Atkinson J, Bachmane F. High affinity binding sites for Glu-plasminogen unveiled by limited plasmic degradation of human fibrin. Eur J Biochem 1986; 160: 599-604
• 20 Suenson E, Petersen LCh. Fibrin and plasminogen structures essential to stimulation of plasmin formation by t-PA. Biochim Biophys Acta 1986; 870: 510-519
• 21 Gething M-J, Adler B, Boose J-A, Gerard RD, Madison EL, McGooky D, Meidell RS, Roman LM, Sambrook J. Variants of human t-PA that lack specific structural domains of the heavy chain. EMBO J 1988; 7: 2731-2740
• 22 Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human t-PA. J Biol Chem 1982; 257: 2912-2919
• 23 Ranby M. Studies on the kinetics of plasminogen activation by t-PA. Biochim Biophys Acta 1982; 704: 461-469
• 24 Loscalzo J. Structural and kinetic comparison of recombinant human single- and two-chain t-PA. J Clin Invest 1988; 823: 1391-1397